Skip to main content
. 2021 Nov 11;14:4595–4607. doi: 10.2147/RMHP.S329387

Table 3.

Community Pharmacists’ Knowledge and Attitude to Pediatric Pain in Nigeria According to Their Demographic and Clinical Profiles (N=375)

Characteristics Correct Answers M±SD (%) Incorrect Answers M±SD (%) Unsure Answers M±SD (%) t-test Statistics tc; ti; tu F- test /Statistics Eta2t; Eta2f; Ec; Ei; Eu
Gender
Male 10.06±5.19(41.9) 9.78±4.20(40.8) 4.16±3.36(17.3) 4.98p; −5.90p; 0.06; 0.09;
Female 9.90±6.13(41.3) 9.82±4.98(40.9) 4.28±4.15(17.8) −2.91p 0.02
Add. Qualifications
Yes 10.02±5.15(41.7) 9.92±4.03(41.3) 4.07±3.80(16.9) 4.33p; 5.16p; 0.05; 0.07
No 9.97±5.61(41.6) 9.74±4.57(40.6) 4.26±4.57(17.8) −2.39p 0.02
Second degree types
Clinically-related 10.02±5.32(41.8) 9.98±4.33(41.6) 4.00±3.88(16.7) 6.34p; 7.72p; 0.27; 0.35
Non-clinically related 9.44±5.67(39.4) 9.72±4.07(40.6) 4.80±4.88(20.0) −3.04q 0.08
Practiced elsewhere before comm. pharm.
Yes 10.16±5.35(41.4) 9.83±4.09(41.6) 4.01±3.58(17.0) 4.26q; 5.38p; 0.05; 0.07
No 9.70±5.68(40.4) 9.73±4.88(40.5) 2.15±4.31(19.1) 2.21p 0.01
Cause of pain
Known 10.02±5.53(41.7) 9.82±4.90(41.7) 4.17±3.87(17.4) 7.16p; 7.90p; 0.20; 0.24;
Not known 9.77±5.40(40.7) 9.65±4.84(40.2) 4.58±4.00(19.1) 4.14q 0.08
Age group (years)
20–29 9.75±5.79(40.6) 9.75±4.78(40.6) 4.5±3.26(18.8) 2.858p 0.03
30–39 10.35±5.70(43.1) 10.08±4.79(42.0) 3.57±1.70(14.9)
a40–49 10.78±5.80(44.9) 9.16±5.11(38.2) 4.06±4.36(16.9)
b50–59 9.15±6.62(38.1) 10.14±4.39(42.3) 4.71±3.91(19.6)
≥60 8.10±6.07(33.8) 10.24±5.05(42.6) 5.66±2.79(23.6)
Ownership
Self-owned 9.76±5.39(40.7) 9.84±4.25(41.0) 4.40±1.90(18.3) 3.643p 0.02
Joint ownership 9.24±5.72(38.5) 10.00±4.70(41.7) 4.76±2.24(19.8)
In employment 10.74±5.83(44.8) 9.65±4.87(40.2) 3.61±1.82(15.0)
Geopolitical zones
North-central 9.80±5.26(40.8) 10.17±3.69(42.4) 4.03±1.46(16.8) 4.497p 0.06
North-east 10.91±5.51(45.5) 8.83±4.77(36.8) 4.26±2.30(17.8)
aNorth-west 10.40±5.91(43.3) 9.65±4.95(40.2) 3.95±2.03(16.5)
cSouth-east 10.27±4.63(42.8) 8.67±2.53(36.2) 5.06±1.48(21.1)
South-south 10.11±5.13(42.2) 9.53±5.30(39.7) 4.36±2.42(18.2)
bSouth-west 9.17±6.32(38.2) 10.38±5.08(43.3) 4.45±2.18(18.5)
Years of practice
a1–10 10.36±5.40(43.2) 9.87±4.33(41.1) 3.77±1.65(15.7) 3.985p 0.03
c11–20 10.29±6.17(42.9) 9.54±5.31(39.8) 4.17±2.32(17.3)
d21–30 9.40±5.26(39.2) 9.58±4.44(39.9) 5.02±2.33(20.9)
b31–40 8.28±6.70(34.5) 10.38±5.08(43.3) 5.34±2.67(22.2)
Perceived cause
bDisease-related 9.21±5.50(38.4) 10.23±5.30(42.6) 4.56±2.36(19.0) 4.168p 0.06
aSocial-related 11.02±6.08(45.9) 9.41±5.02(39.2) 3.57±1.90(14.9)
Menstruation 8.70±2.98(36.3) 10.2±1.09(42.5) 5.10±0.55(21.2)
Not reported 9.70±5.72(40.4) 9.70±5.05(40.4) 4.60±2.39(19.2)
Ever trained
Yes 10.38±5.31(43.3) 9.57±4.04(39.9) 4.05±1.71(16.9) 3.587p 0.02
No 9.71±5.73(40.5) 10.02±4.90(41.8) 4.27±2.09(17.8)
Cannot remember 9.35±5.58(39.0) 9.87±4.94(41.1) 4.78±2.39(19.9)

Notes: a, b, c, d-categories of each group where the statistical significance in mean difference lie; pP<0.05; qP≤0.005.

Abbreviations: M±SD, Mean±Standard deviation; %, Percentage of those with the respective mean knowledge score; F, statistics-For One-Way analysis of variance (ANOVA); tc, t-test statistic for correct answers; ti, t-test statistic for incorrect answers; tu-, t-test statistic for unsure answers; F, test: statistic for one-way analysis of variance; Eta2t, for t-test; Eta2f, for one-way analysis of variance; Ec, Eta2 for correct answers; Ei, Eta2 for incorrect answers; Eu, Eta2 for unsure answers; Add., Additional; comm., community; pharm., pharmacy.